ArticleBritish journal of cancer2015

TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial.

J M S Bartlett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.